Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO)
CUSIP: 09075F305
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 138,961,039
- Total 13F shares
- 1
- Share change
- 0
- Total reported value
- $2
- Price per share
- $2.00
- Number of holders
- 1
Quarterly Holders Quick Answers
What is CUSIP 09075F305?
CUSIP 09075F305 identifies BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075F305:
Top shareholders of BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Soheil Shams |
3/4/5
|
Chief Informatics Officer |
—
mixed-class rows
|
5,556,479
mixed-class rows
|
$3,217,163 | — | 15 Feb 2022 | |
| Lincoln Alternative Strategies LLC |
13D/G
|
— |
5.4%
|
525,000
|
$2,021,250 | $0 | 17 Sep 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
508,415
|
$1,957,398 | $0 | 16 Sep 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
7.7%
|
10,700,000
|
$1,284,000 | $0 | 03 Jan 2025 | |
| Iroquois Capital Management, LLC |
13D/G
|
Richard Abbe |
5%
|
98,944
|
$1,088,384 | $0 | 30 Sep 2025 | |
| Ayrton Capital LLC |
13D/G
|
— |
10%
|
528,245
|
$903,140 | $0 | 30 Sep 2025 | |
| Christopher P. Stewart |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
281,373
|
$180,810 | — | 12 May 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.36%
|
40,076
|
$131,000 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
18,871
|
$61,901 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
11,655
|
$38,228 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.09%
|
9,936
|
$32,590 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
8,409
|
$27,582 | — | 30 Jun 2025 | |
| Gulsen Kama |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
91,000
mixed-class rows
|
$20,320 | — | 03 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
3,195
|
$10,476 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,670
|
$8,758 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
2,308
|
$7,570 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
1,525
|
$5,002 | — | 30 Jun 2025 | |
| SUMMIT SECURITIES GROUP LLC |
13F
|
Company |
0.01%
|
1,199
|
$3,933 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
281
|
$922 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
113
|
$371 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
74
|
$243 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
56
|
$184 | — | 30 Jun 2025 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0%
|
16
|
$52 | — | 30 Jun 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
14
|
$46 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
12
|
$39 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
6
|
$20 | — | 30 Jun 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
4
|
$13 | — | 30 Jun 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
3
|
$10 | — | 30 Jun 2025 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
3
|
$10 | — | 30 Jun 2025 | |
| Pandora Wealth, Inc. |
13F
|
Company |
0%
|
3
|
$10 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
2
|
$7 | — | 30 Jun 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
13
|
$4 | — | 30 Jun 2025 | |
| Ancora Advisors LLC |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2025 | |
| Aviso Financial Inc. |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2025 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2025 | |
| Medallion Wealth Advisors, LLC |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2025 | |
| Richard Shippy |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
550,000
|
— | — | 15 Feb 2022 | |
| Robert J. Priar |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
400,000
|
— | — | 01 Jun 2021 | |
| Vincent Jung-Fai Wong |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 18 Jun 2024 | |
| Albert Luderer |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Aleksandar Rajkovic |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Christopher J. Twomey |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| David L. Barker |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Hannah Mamuszka |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Kristiina Vuori MD |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Yvonne Linney |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 |
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q3 2025
As of 30 Sep 2025,
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1 shares.
The largest 1 holders included
Ancora Advisors LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
1
Q3 2025 holders
1
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.